ITU Unit Action

VEREGEN

MEDIGENE AG

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 78862546 FILING DATE 04/17/2006
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY MCMORROW, JANICE LEE
L.O. ASSIGNED 115

PUB INFORMATION

RUN DATE 02/10/2009
PUB DATE 11/28/2006
STATUS 733-FOURTH EXTENSION - GRANTED
STATUS DATE 02/09/2009
LITERAL MARK ELEMENT VEREGEN

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT VEREGEN
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME MEDIGENE AG
ADDRESS Lochhamer Strasse 11
Martinsried, 
ENTITY 03-CORPORATION
CITIZENSHIP Germany

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical products for topical application, namely, pharmaceutical preparations for use in treating the skin diseases of verruca vulgaris, verruca plantaris, verruca plana, flat condylomata, mosaic-type warts, butcher's warts, hyperplasia of the epidermis, recalcitrant cutaneous warts, herpes infection, genital and anal herpes infection, shingles, Molluscum contagiosum, mycosis, mycosis fungoides, tinea, tinea pedis, pigmentation disorders, hyperpigmentation, hypopigmentation, vitiligo, melasma, atypical/displastic/melanocytic nevi, sun-damaged skin, removal of tattoos, psoriasis, neurodermitis, dermatitis, atopic dermatitis, cutaneous atopy, eczema, lichen planus, cutaneous lupus erythematosus, skin ulcers, rosacea, precancerous and cancerous lesions, increased proliferation of skin cells, actinic keratosis, actinic cheilitis, keloids, lentigo, hemangioma, Epidermodysplasia verruciformis, Bowen's disease, Bowenoid papulosis, basal cell carcinoma, intraepithelial squamous cell carcinoma, melanoma, and other skin cancers, neoplasias, cervical dysplasia, cervical intraepithelial neoplasias, anal intraepithelial neoplasias, vulvar intraepithelial neoplasia, penile cancer, vulvovaginal cancer, anal carcinoma, cervical carcinoma, cutaneous T-cell lymphoma, alopecia, vulvodynia, keloid and hypertrophic scars, post surgical excision on scar cosmesis, hyperkeratosis, seborrhea, Darier's disease, porokeratosis of mibelli, ichthyosis, xerosis, dartroud disthesis, acne, nasal papilloma, oral papilloma, focal epithelial hyperplasia, laryngeal papilloma, recurrent respiratory papillomatosis and conjunctival papilloma

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
PARENT OF

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
02/09/2009 EX4G S EXTENSION 4 GRANTED 036
02/06/2009 EXT4 S EXTENSION 4 FILED 035
02/06/2009 EEXT I TEAS EXTENSION RECEIVED 034
08/07/2008 EX3G S EXTENSION 3 GRANTED 033
07/28/2008 EXT3 S EXTENSION 3 FILED 032
08/07/2008 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL 031
07/28/2008 EEXT I TEAS EXTENSION RECEIVED 030
05/07/2008 EX2G S EXTENSION 2 GRANTED 029
02/20/2008 EXT2 S EXTENSION 2 FILED 028
04/23/2008 PGEX O PETITION GRANTED - EXTENSION REQUEST FILED 027
04/18/2008 APET A ASSIGNED TO PETITION STAFF 026
04/14/2008 PETR I PETITION TO REVIVE-RECEIVED 025
04/14/2008 MAIL I PAPER RECEIVED 024
03/11/2008 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED 023
03/11/2008 ABN6 S ABANDONMENT - NO USE STATEMENT FILED 022
03/11/2008 CORV P REVIEW OF CORRESPONDENCE COMPLETE 021
03/06/2008 FAXX I FAX RECEIVED 020
03/06/2008 FAXX I FAX RECEIVED 019
03/06/2008 FAXX I FAX RECEIVED 018
03/06/2008 DPCC D DIVISIONAL PROCESSING COMPLETE 017
02/08/2008 DRRR I DIVISIONAL REQUEST RECEIVED 016
03/03/2008 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED 015
02/08/2008 MAIL I PAPER RECEIVED 014
12/03/2007 DOCK D ASSIGNED TO EXAMINER 013
08/09/2007 EX1G S EXTENSION 1 GRANTED 012
08/09/2007 EXT1 S EXTENSION 1 FILED 011
08/09/2007 EEXT I TEAS EXTENSION RECEIVED 010
02/20/2007 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT 009
11/28/2006 PUBO A PUBLISHED FOR OPPOSITION 008
11/08/2006 NPUB O NOTICE OF PUBLICATION 007
10/06/2006 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED 006
10/05/2006 ALIE A ASSIGNED TO LIE 005
09/29/2006 ALIE A ASSIGNED TO LIE 004
09/22/2006 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 003
09/22/2006 DOCK D ASSIGNED TO EXAMINER 002
04/21/2006 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Linda M. Byrne
CORRESPONDENCE ADDRESS Linda M. Byrne
Crawford Maunu PLLC
1150 Northland Drive, Suite 100
St. Paul MN 55120
DOMESTIC REPRESENTATIVE Linda M. Byrne

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME MEDIGENE AG
ADDRESS Lochhamer Strasse 11
Martinsried, 
ENTITY 03-CORPORATION
CITIZENSHIP Germany

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed